Bilaketaren emaitzak - Amy E. Armstrong
- Erakusten 1 - 11 emaitzak -- 11
-
1
Cell‐free DNA next‐generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal... nork Amy E. Armstrong, Jenna Rossoff, Desiree Hollemon, David K. Hong, William J. Muller, Sonali Chaudhury
Argitaratua 2019Artigo -
2
-
3
Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001) nork Panagiotis A. Konstantinopoulos, William E. Brady, John Farley, Amy E. Armstrong, Denise Uyar, David M. Gershenson
Argitaratua 2018Artigo -
4
-
5
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells nork Frances M. Saccoccio, Anne Sauer, Xiaohong Cui, Amy E. Armstrong, El‐Sayed E. Habib, David C. Johnson, Brent J. Ryckman, Aloysius J. Klingelhutz, Stuart P. Adler, Michael A. McVoy
Argitaratua 2011Artigo -
6
Advances in the clinical management of high‐risk Wilms tumors nork Michael V. Ortiz, Christa Koenig, Amy E. Armstrong, Jesper Brok, Beatriz de Camargo, Annelies M. C. Mavinkurve‐Groothuis, Thelma B. Velasquez Herrera, Rajkumar Venkatramani, Andrew D. Woods, Jeffrey S. Dome, Filippo Spreafico
Argitaratua 2023Revisão -
7
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation nork Steven D. Rhodes, Yongzheng He, Abbi E. Smith, Jiang Li, Qingbo Lu, Julie A. Mund, Xiaohong Li, Waylan Bessler, Shaomin Qian, William E. Dyer, George E. Sandusky, Andrew Horvai, Amy E. Armstrong, D. Wade Clapp
Argitaratua 2019Artigo -
8
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial nork Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp
Argitaratua 2021Artigo -
9
Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG) nork Ami V. Desai, Giles Robinson, Karen Gauvain, Ellen M. Basu, Margaret E. Macy, Luke Maese, Nicholas Whipple, Amit J. Sabnis, Jennifer H. Foster, Suzanne Shusterman, Janet Yoon, Brian Weiss, Mohamed S Abdelbaki, Amy E. Armstrong, Thomas F. Cash, Christine A. Pratilas, Nadège Corradini, Lynley V. Marshall, Mufiza Farid‐Kapadia, Saibah Chohan, Clare Devlin, Georgina Meneses‐Lorente, Alison K. Cardenas, Katherine E. Hutchinson, Guillaume Bergthold, Hubert Caron, Edna Chow Maneval, Amar Gajjar, Elizabeth Fox
Argitaratua 2022Artigo -
10
A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor nork Samantha Gadd, Vicki Huff, Amy L. Walz, Ariadne H.A.G. Ooms, Amy E. Armstrong, Daniela S. Gerhard, Malcolm A. Smith, Jaime M. Guidry Auvil, Daoud Meerzaman, Qing-Rong Chen, Chih Hao Hsu, Chunhua Yan, Cu Nguyen, Ying Hu, Leandro C. Hermida, Tanja M. Davidsen, Patee Gesuwan, Yussanne Ma, Zusheng Zong, Andrew J. Mungall, Richard A. Moore, Marco A. Marra, Jeffrey S. Dome, Charles G. Mullighan, Jing Ma, David A. Wheeler, Oliver Hampton, Nicole Ross, Julie M. Gastier‐Foster, Stefan T. Arold, Elizabeth J. Perlman
Argitaratua 2017Artigo -
11
LINC-08. Neuro-Oncology tumor board – one-year experience of international collaboration nork Margaret Shatara, Evan Cantor, Ashley Meyer, Andrea Ogle, Kimberly Hofmann, Tammy Green, Mary Beck, Michele McHugh, Nicole M Brossier, Andrew Cluster, Ali Mian, Sonika Dahiya, Zeyad Abdelaziz, Shady Fadel, Nahla Ali Mobark, Musa Alharbi, Soad K. Al Jaouni, Abrar Aljunaid, Waleed Said, Moatasem El‐Ayadi, Madeha Mahmoud, Abeer Al-Battashi, I. Chabchoub, Nisreen Khalifa, Nora F. Dengler, Pablo Hernáiz Driever, Nicolás Rojas del Río, Bożenna Dembowska‐Bagińska, Marta Perek‐Polnik, Szymon Skoczeń, Hetal Dholaria, Sumanth Nagabushan, Milena Oliveira, Angela C. Hirbe, Amy E. Armstrong, David D. Limbrick, David H. Gutmann, Mohamed S Abdelbaki
Argitaratua 2022Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Medicine
Internal medicine
Biology
Cancer
Oncology
Cancer research
Surgery
Adverse effect
Cabozantinib
Chemotherapy
Gene
Genetics
Immunology
Intensive care medicine
Neurofibromatosis
Pathology
Progressive disease
Wilms' tumor
Adenocarcinoma
Antibody
Aspergillosis
Biopsy
CDKN2A
Cell biology
Center (category theory)
Chemistry
Clinical endpoint
Clinical trial
Colorectal cancer
Computer science